Related Experiment Video
Updated: May 26, 2025
08:41
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
9.7K
Purinergic Receptor P2Y1 Modulates Catecholamine Signaling in Murine Mesenteric Lymph Nodes.
Alexandra K Brooke1, Sarbeshwar Ojha1, Daniel P Murrow1
1Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45221. United States.
ACS Chemical Neuroscience
|February 24, 2025
Summary
Researchers discovered that adenosine triphosphate (ATP) release in lymph nodes regulates norepinephrine signaling. Manipulating ATP receptors impacts catecholamine levels, offering insights into neuroimmune communication and potential therapeutic targets.
Area of Science:
- Neuroimmunology
- Neurotransmitter signaling
- Sympathetic nervous system function
Background:
- Neuroimmune communication is essential for physiological responses and immune homeostasis.
- Adrenergic and purinergic signaling within the sympathetic nervous system are key to this communication.
Purpose of the Study:
- To achieve the first co-detection of purines and catecholamines in mesenteric lymph nodes.
- To investigate the impact of manipulating ATP receptors on catecholamine signaling in lymph nodes.
Main Methods:
- Fast-scan cyclic voltammetry for co-detection of adenine-based purines and catecholamines.
- Pharmacological manipulation using a P2Y1 receptor antagonist (MRS2179).
Main Results:
- Co-detection of purines and catecholamines in mesenteric lymph nodes was successful.
- Targeting the P2Y1 receptor with MRS2179 decreased catecholamine concentrations.
- MRS2179 altered catecholamine event dynamics, making them smaller, less frequent, and longer-lasting, potentially due to reduced intracellular Ca2+.
Conclusions:
- ATP release in lymph nodes partially regulates norepinephrine signaling.
- This study provides mechanistic insights into sympathetic neuronal neurotransmitter control.
- Understanding these neuroimmune mechanisms may inform future therapeutic strategies in immunology and neurobiology.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:26Adrenergic Receptors: β Subtype
1.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.5K
01:31Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
01:25Cholinergic Receptors: Muscarinic
1.8K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
1.8K
01:27Adrenergic Receptors (Adrenoceptors): Classification
2.2K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.2K